| Literature DB >> 25874752 |
Kelly van Drielen1, David A Gunn, Raymond Noordam, Christopher E M Griffiths, Rudi G J Westendorp, Anton J M de Craen, Diana van Heemst.
Abstract
Circulatory levels of insulin-like growth factor (IGF-1), glucose, and cortisol have been previously associated with facial aging. However, as these serum measures are related, it is unclear whether their associations with skin aging occur independently from each other. We aimed to investigate whether the associations between serum IGF-1, glucose, and cortisol levels and perceived age/wrinkle grade occur independently of each other and whether these are mediated via skin wrinkling or via other skin aging features. Perceived age and skin wrinkling grade were assessed in a random sample from the Leiden Longevity Study with non-fasted (N = 579) and fasted blood sampling (N = 219). In our study population, a higher non-fasted IGF-1 level was associated with a lower skin wrinkling grade (p value = 0.014) and tended to associate with a lower perceived age (p value = 0.067), which was mediated for approximately 100 % by skin wrinkling. A higher non-fasted glucose level was associated with a higher perceived age (p value = 0.017), which was mediated for 51 % by skin wrinkling grade (p value = 0.112). A higher fasted cortisol level tended to associate with a higher perceived age (p value = 0.116), which was mediated for 29 % by skin wrinkling. Results remained similar when the serum measures were statistically adjusted for each other. Thus, the previously reported serum measures associate independently from each other with skin aging. IGF-1 is predominantly associated with perceived age by skin wrinkling, whereas cortisol and glucose also by other skin aging features.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25874752 PMCID: PMC4397216 DOI: 10.1007/s11357-015-9771-3
Source DB: PubMed Journal: Age (Dordr) ISSN: 0161-9152
Characteristics of the study populations
| Non-fasted cohort ( | Fasted cohort ( | |
|---|---|---|
| Women ( | 315 (54.4) | 117 (53.4) |
| Offspring ( | 298 (51.5) | 113 (51.6) |
| Chronological age (years) | 62.8 ± 6.8 | 63.3 ± 6.8 |
| Perceived age (years) | 59.5 ± 7.8 | 59.5 ± 7.9 |
| Wrinkle grade (points) | 4.6 ± 1.3 | 4.6 ± 1.3 |
| Serum blood parameters | ||
| Non-fasted IGF-1/IGFBP3 molar ratio | 0.113 ± 0.03 | 0.113 ± 0.02 |
| Non-fasted glucose (mmol L−1) | 5.8 ± 1.1 | 5.7 ± 0.9 |
| Fasted IGF-1/IGFBP3 molar ratio | 0.105 ± 0.03 | |
| Fasted glucose (mmol L−1) | 5.1 ± 0.5 | |
| Fasted cortisol (mmol L−1) | 0.504 ± 0.1 | |
| Current smoking ( | 74 (12.8) | 21 (9.6) |
| Body mass index (kg/m2) | 26.4 ± 3.9 | 26.3 ± 3.8 |
All continuous date are presented as means with standard deviation, unless otherwise stated
Abbreviations: IGF-1 insulin-like growth factor-1, IGFBP3 IGF-binding protein 3
Perceived age and wrinkle grade in tertiles of the IGF-1/IGFBP3 molar ratio and glucose (separate and combined model)—non fasted
| Tertiles of parameter | ||||||||
|---|---|---|---|---|---|---|---|---|
| Separate model (only IGF-1/IGFBP3 or glucose) | Combined model (IGF-1/IGFBP3 and glucose) | |||||||
| Low | Medium | High | Beta (SE)a | Low | Medium | High | Beta (SE)a | |
| IGF-1/IGFBP3 ratio | ||||||||
|
| 193 | 193 | 193 | 193 | 193 | 193 | ||
| Range | 0.05–0.101 | 0.102–0.121 | 0.122–0.23 | 0.05–0.101 | 0.102–0.121 | 0.122–0.23 | ||
| Perceived age (years)b | 61.1 (60.3–62.0) | 61.0 (60.1–61.9) | 60.1 (59.2–61.0) | −0.49 (0.27)* | 61.0 (60.2–61.9) | 61.0 (60.1–61.9) | 60.2 (59.3–61.1) | −0.42 (0.27) |
| Perceived age (years)c | 59.9 (59.4–60.5) | 60.2 (59.7–60.8) | 60.0 (59.4–60.5) | 0.01 (0.17) | 59.9 (59.3–60.4) | 60.2 (59.7–60.8) | 60.0 (59.4–60.6) | 0.05 (0.17) |
| Wrinkle grade (points)b | 4.98 (4.79–5.16) | 4.86 (4.67–5.05) | 4.70 (4.51–4.89) | −0.14 (0.06)** | 4.97 (4.78–5.15) | 4.86 (4.67–5.04) | 4.71 (4.52–4.90) | −0.13 (0.06) |
| Glucose | ||||||||
|
| 197 | 195 | 187 | 197 | 195 | 187 | ||
| Range (mmol L−1) | 3.3–5.2 | 5.3–6.1 | 6.2–10.5 | 3.3–5.2 | 5.3–6.1 | 6.2–10.5 | ||
| Perceived age (years)b | 60.1 (59.2–61.0) | 60.8 (59.9–61.7) | 61.4 (60.5–62.3) | 0.63 (0.27)** | 60.2 (59.3–61.0) | 60.8 (59.9–61.7) | 61.3 (60.4–62.2) | 0.58 (0.27)** |
| Perceived age (years)c | 59.8 (59.2–60.3) | 60.0 (59.5–60.6) | 60.3 (59.7–60.9) | 0.31 (0.17) | 59.8 (59.2–60.3) | 60.1 (59.5–60.6) | 60.3 (59.7–60.9) | 0.31 (0.17) |
| Wrinkle grade (points)b | 4.75 (4.56–4.94) | 4.87 (4.68–5.05) | 4.95 (4.77–5.14) | 0.09 (0.06)* | 4.76 (4.57–4.95) | 4.85 (4.66–5.04) | 4.93 (4.74–5.11) | 0.07 (0.06) |
Data are presented as means with 95 % confidence intervals unless otherwise stated
IGF-1 insulin-like growth factor-1, IGFBP3 IGF-binding protein 3
*p value <0.10; **p value <0.05
aBeta estimated depicted as the average difference in outcome and standard error between subsequent strata
bAdjusted for offspring/partner status, gender, chronological age, BMI, and current smoking
cAdjusted for offspring/partner status, gender, chronological age, BMI, current smoking, and skin wrinkling
Perceived age and wrinkle grade in tertiles of the IGF-1/IGFBP3 molar ratio, glucose, and cortisol (separate and combined model)—fasted
| Tertiles of parameter | ||||||||
|---|---|---|---|---|---|---|---|---|
| Separate model (only IGF-1/IGFBP3, glucose, or cortisol) | Combined model (IGF-1/IGFBP3, glucose, and cortisol) | |||||||
| Low | Medium | High | Beta (SE)a | Low | Medium | High | Beta (SE)a | |
| IGF-1/IGFBP3 ratio | ||||||||
|
| 73 | 73 | 73 | 73 | 73 | 73 | ||
| Range | 0.05–0.093 | 0.094–0.113 | 0.114–0.19 | 0.05–0.093 | 0.094–0.113 | 0.114–0.19 | ||
| Perceived age (years)b | 61.7 (60.1–63.3) | 61.0 (59.4–62.6) | 60.2 (58.6–61.8) | −0.72 (0.47) | 61.4 (59.8–63.1) | 60.8 (59.2–62.4) | 60.1 (58.5–61.8) | −0.63 (0.47) |
| Perceived age (years)c | 60.3 (59.3–61.4) | 59.6 (58.6–60.7) | 59.5 (58.5–60.5) | −0.41 (0.30) | 60.3 (59.2–61.3) | 59.6 (58.6–60.7) | 59.4 (58.3–60.4) | −0.37 (0.30) |
| Wrinkle grade (points)b | 4.96 (4.63–5.28) | 4.96 (4.63–5.28) | 4.80 (4.47–5.13) | −0.08 (0.09) | 4.91 (4.58–5.25) | 4.91 (4.58–5.24) | 4.80 (4.46–5.14) | −0.07 (0.09) |
| Glucose | ||||||||
|
| 81 | 67 | 71 | 81 | 67 | 71 | ||
| Range (mmol L−1) | 3.7–4.8 | 4.9–5.2 | 5.3–6.7 | 3.7–4.8 | 4.9–5.2 | 5.3–6.7 | ||
| Perceived age (years)b | 60.7 (59.0–62.4) | 60.2 (58.5–61.9) | 61.5 (60.1–63.0) | 0.43 (0.46) | 60.7 (59.0–62.4) | 60.2 (58.5–61.9) | 61.4 (60.0–62.9) | 0.36 (0.46) |
| Perceived age (years)c | 59.9 (58.8–61.0) | 59.2 (58.1–60.3) | 60.1 (59.2–61.1) | 0.15 (0.30) | 60.0 (58.9–61.1) | 59.2 (58.1–60.3) | 60.1 (59.1–61.0) | 0.11 (0.30) |
| Wrinkle grade (points)b | 4.80 (4.46–5.15) | 4.88 (4.53–5.23) | 4.98 (4.68–5.28) | 0.08 (0.09) | 4.79 (4.44–5.14) | 4.86 (4.51–5.22) | 4.97 (4.67–5.27) | 0.07 (0.10) |
| Cortisol | ||||||||
|
| 72 | 74 | 73 | 72 | 74 | 73 | ||
| Range (mmol L−1) | 0.023–0.429 | 0.430–0.549 | 0.550–0.952 | 0.023–0.429 | 0.430–0.549 | 0.550–0.952 | ||
| Perceived age (years)b | 60.2 (58.6–61.8) | 61.2 (59.6–62.7) | 61.6 (60.0–63.2) | 0.73 (0.44) | 60.1 (58.5–61.7) | 60.9 (59.3–62.5) | 61.4 (59.8–63.0) | 0.67 (0.44) |
| Perceived age (years)c | 59.6 (58.5–60.6) | 59.5 (58.5–60.5) | 60.5 (59.5–61.6) | 0.52 (0.30)* | 59.5 (58.5–60.6) | 59.3 (58.3–60.4) | 60.4 (59.4–61.4) | 0.49 (0.29) |
| Wrinkle grade (points)b | 4.77 (4.44–5.10) | 5.05 (4.73–5.36) | 4.89 (4.56–5.21) | 0.05 (0.09) | 4.75 (4.42–5.09) | 5.02 (4.69–5.34) | 4.86 (4.53–5.19) | 0.05 (0.09) |
Data are presented as means with 95 % confidence intervals unless otherwise stated
IGF-1 insulin-like growth factor-1, IGFBP3 IGF-binding protein 3
*p value <0.10
aBeta estimate depicted as the average difference in outcome and standard error between subsequent strata
bAdjusted for offspring/partner status, gender, chronological age, BMI, and current smoking
cAdjusted for offspring/partner status, gender, chronological age, BMI, current smoking, and skin wrinkling
Fig. 1Schematic overview of the study findings. Abbreviations: f fasted, nf non-fasted. This figure present the possible routes through which non-fasted insulin-like growth factor (IGF)-1/IGF-binding protein (IGFBP) 3 molar ratio and non-fasted glucose and fasted IGF-1/IGFBP3 molar ratio, fasted glucose, and fasted cortisol influence perceived age. In our data, the association between perceived age and the non-fasted IGF-1/IGFBP3 molar ratio was mediated by skin wrinkling. The associations between the fasted-IGF-1/IGFBP3 molar ratio, non-fasted glucose, and fasted glucose were partially mediated by skin wrinkling and partially via other features, while the association between fasted cortisol and perceived age was mediated predominantly via other features than skin wrinkling